Latest News About Nevanac Eye Drop

Updated 2026-05-07 18:03

Here’s the latest general context on Nevanac (nepafenac) eye drops from reliable sources:

If you’d like, I can:

Would you like me to focus on a particular country or format (bullet summary, patient handout, or quick dosing chart)? I can also fetch the exact smPC excerpts if you want precise language. I’ll include up-to-date citations with each point.

Sources

Nevanac | European Medicines Agency (EMA)

## Nevanac is an eye drop suspension that contains the active substance nepafenac (1 and 3 mg/ml). ## Nevanac is used in adults to prevent and treat the pain and inflammation that can occur after an operation to remove a cataract from the eye. Nevanac is also used to reduce the risk of macular oedema (swelling in the macula, the central part of the retina at the back of the eye) that can occur after cataract surgery in adult diabetes patients. The medicine can only be obtained with a...

www.ema.europa.eu

[PDF] Nevanac, INN-napafenac - EMA

immediately discontinue use of NEVANAC and should be monitored closely for corneal health (see section 4.4). From post-marketing experience with NEVANAC 1 mg/ml eye drops, suspension, cases reporting corneal epithelium defect/disorder have been identified. Severity of these cases vary from non serious

www.ema.europa.eu

nepafenac 1mg/mL eye drops, suspension (Nevanac®) ...

NHS Scotland. The advice is summarised as follows: ADVICE: following a full submission nepafenac (Nevanac®) is accepted for use within NHS Scotland. Indication under review: reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients. In the pivotal study which included diabetic patients who had undergone cataract surgery, nepafenac eye drops significantly reduced the incidence of macular oedema compared to vehicle. Overleaf is the detailed...

scottishmedicines.org.uk